Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Human Immunodeficiency Virus (HIV) Diagnosis Market From 2025 To 2029?
The market size for diagnosing the human immunodeficiency virus (hiv) has seen substantial growth recently. It’s projected to increase from $4.2 billion in 2024 to $4.67 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.2%. The historical growth can be linked to the enlargement of voluntary counseling and testing, the innovation in HIV antibody tests, the occurrence of the HIV/AIDS epidemic, and initiatives led both by communities and peers.
Expect swift expansion in the upcoming years for the market of human immunodeficiency virus (hiv) diagnosis. The projected increase is to approximate$6.88 billion by 2029 with an annual compound growth rate (CAGR) of 10.1%. This progression can be credited to public health advertising and awareness drives, concentration on equality and inclusion, habitual screenings in healthcare environments, community-oriented and peer-led methodologies, and widening self-examination. Predominant trends for the future entail improvements in examination technologies, a focus on targeted testing approaches, testing and outreach at the community level, prioritization of equity and inclusion, in tandem with policy and financing preferences.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp
Which Factors and External Forces Are Driving Demand in the Human Immunodeficiency Virus (HIV) Diagnosis Market?
The HIV diagnosis market is expected to surge due to the climbing rate of voluntary blood donations. Phlebotomy involves the insertion of a needle into a vein for blood collection and it has seen a significant increase in participation. This boost in blood donations can be attributed to the advancements in medical technology, increased community involvement, and enhancement in tactics for recruiting and retaining donors. A larger pool of blood samples for HIV testing is made available as more individuals donate blood, enabling more thorough screening for HIV antibodies or antigens. This ultimately enhances the precision and dependability of HIV diagnoses. Notably, NHS Blood and Transplant, a governmental agency in the UK, reported an increase in the number of fresh blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. As such, the burgeoning rate of blood donations fuels the expansion of the HIV diagnosis market.
Which Segments in the Human Immunodeficiency Virus (HIV) Diagnosis Offer the Most Growth?
The human immunodeficiency virus (hiv) diagnosismarket covered in this report is segmented –
1) By Product: Consumables; Instruments; Software And Services
2) By Mode: Self-Test; Lab-Based
3) By End User: Diagnostic Laboratories; Hospitals; Research Institutions
Subsegments:
1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits); Reagents And Chemicals; Sample Collection Devices (Blood Collection Tubes, Lancets); Test Strips; Control And Calibration Kits; Disposable Gloves And Safety Equipment
2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers); Hiv Viral Load Testing Equipment; Cd4 Count Analyzers; Point-Of-Care Hiv Diagnostic Devices; Molecular Diagnostic Instruments ( Pcr Machines); Electrochemical And Optical Hiv Detection Instruments
3) By Software: Hiv Diagnosis Data Management Software; Electronic Health Record (Ehr) Integration Software; Hiv Test Result Interpretation Software; Laboratory Information Management Systems (Lims); Patient Monitoring And Tracking Software; Cloud-Based Hiv Diagnostic Reporting Tools
4) By Services: Diagnostic Testing Services; Hiv Testing Support Services ( Counseling, Education); Diagnostic Lab Services; Telemedicine And Remote Hiv Testing Services; Clinical Trial Services For Hiv Diagnostic Tests; Data Analytics And Interpretation Services For Hiv Testing
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15587&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Human Immunodeficiency Virus (HIV) Diagnosis Market?# Market?
North America was the largest region in the HIV diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theHuman Immunodeficiency Virus (HIV) Diagnosis Market’s Growth?
Leading firms active in the HIV diagnosis market are innovating chip-based real-time PCR test solutions for HIV to improve precision, decrease response time, and make them more accessible. Chip-based real-time PCR test solutions for HIV are diagnostic instruments that use devices known as microfluidic chips or small integrated circuits to carry out real-time polymerase chain reaction (PCR) tests to detect HIV. For example, in August 2022, India’s Molbio Diagnostics, a molecular diagnostics manufacturer, introduced the Truenat HIV-1 test. This chip-based real-time PCR test is designed for the quantitative detection and diagnosis of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma, thereby aiding in monitoring the viral load of HIV-1 in patients. This test, founded on Taqman chemistry, boasts high primer sensitivity and specificity. Only a minimum sample volume of 6 mcL is required for the test. It also includes an intelligent chip with lot-specific data for results quantification. The test is equipped with a chip reuse lock and a reaction port designed to resist contamination and evaporation.
View the full report here:
What Are the Key Elements That Define the Human Immunodeficiency Virus (HIV) Diagnosis Market?
Human immunodeficiency viruses (HIV) diagnosis refers to the process of determining whether an individual has been infected with the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome. This diagnosis involves testing for the presence of HIV antibodies, antigens, or viral genetic material in a person’s blood, saliva, or other bodily fluids.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15587
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
